Hangzhou-based Chinese e-commerce giant Alibaba Group has acquired 54% in Chinese pharmaceutical data firm CITIC 21CN for around HK$1.3 billion ($170 million), according to a security filing. Hong Kong-listed CITIC 21CN is a subsidiary of Chinese state-owned conglomerate CITIC Group. Aside from Alibaba, Yunfeng Capital, a Shanghai-based private equity firm set up by Alibaba’s founder […]

Visit ChinaMoneyNetwork.com for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.